Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
VintaBio Unveils $64M to Back Viral Vector Trailblazers Behind the First Approved Cell and Gene Therapies
VintaBio, a life sciences company with unmatched industry expertise helping alleviate the viral vector bottleneck […]
SentiAR Announces Close of $8.5 million Series B Financing
SentiAR, a St. Louis, Missouri-based pioneer in using Augmented Reality (AR) visualization technology for medical procedures, […]
CTRL Therapeutics Launches with $10M Seed Financing to Advance Next-Generation Cell Therapy Platform for the Treatment of Solid Tumors
CTRL Therapeutics, a biotechnology company developing a next-generation cell therapy platform for solid tumors, has […]
Consumer Longevity Company Tally Health™ Announces $10M Seed Round Led by Forerunner Ventures with Celebrity Participation
Tally Health, a revolutionary consumer biotechnology company created to change the way we age, announces […]
Canaan Closes $850 Million to Continue 35-Year History of Building and Supporting Transformational Technology and Healthcare Companies
Canaan today announced $850 million in new capital to continue the firm’s 35-year history of […]
Felix Raises $18M CDN to Scale On-Demand Treatment for Everyday Health
Felix, Canada’s leading provider of on-demand treatment for everyday health, announces it has completed its […]
Cystic Fibrosis Foundation Commits Up to $15.5M in Additional Funding for Potential Enzyme Therapy
The Cystic Fibrosis Foundation recently agreed to provide up to $15.5 million to Anagram Therapeutics […]
Vivani Medical Announces $1 Million NIH Grant Funding to Support Cortigent’s Ongoing Orion Clinical Study
Vivani Medical, an emerging biopharmaceutical company that develops miniaturized, subdermal implants has announced that the […]
Genialis Raises $13M in Financing to Build Clinical Biomarkers that Predict Patient Response
Genialis, a computational precision medicine company unraveling complex biology to find new ways to address […]
Salubris Biotherapeutics Announces $35 Million Financing to Advance Development Activities and Provides Pipeline Updates
Salubris Biotherapeutics, a clinical-stage biotechnology company dedicated to discovering and developing novel complex biologic therapeutics, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more